Sumatriptan Spray
Product Images NDC 66993-082

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 66993-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Chemical Structure (Sumatriptannasalspray Spl Graphic 01)

Chemical structure of sumatriptan, the active ingredient in SUMATRIPTAN nasal spray. The diagram shows the molecular arrangement including indole and sulfonamide functional groups.*

FDA Label Image

Figure 1 (Sumatriptannasalspray Spl Graphic 02)

A line graph showing the estimated probability of response over time (minutes) from initial dose for sumatriptan nasal spray clinical data. The graph compares placebo with 5 mg, 10 mg, and 20 mg doses, indicating increasing probabilities of response with higher doses over a 120-minute period.*

FDA Label Image

Figure 2 (Sumatriptannasalspray Spl Graphic 03)

A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose. The graph compares placebo and three doses (5 mg, 10 mg, 20 mg), with the probability increasing over time and higher doses showing greater efficacy than placebo.*

FDA Label Image

Figure A (Sumatriptannasalspray Spl Graphic 04)

Sumatriptan nasal spray label showing the proprietary name SUMATRIPTAN and strength 8.6 mg/0.1 mL. The label is being peeled from a backing, revealing black and red text on a white sticker held by a hand against a blue background.*

FDA Label Image

Figure B (Sumatriptannasalspray Spl Graphic 05)

FDA Label Image

Figure C (Sumatriptannasalspray Spl Graphic 06)

An instructional illustration showing a woman using a nasal spray, with the spray tip inserted into one nostril and the head tilted slightly back, demonstrating the proper nasal spray administration technique.*

FDA Label Image

Figure D (Sumatriptannasalspray Spl Graphic 07)

An instructional image showing a hand holding a SUMATRIPTAN nasal spray device, labeled to identify the nozzle and plunger components for user guidance.*

FDA Label Image

Figure E (Sumatriptannasalspray Spl Graphic 08)

An instructional image showing a woman using SUMATRIPTAN nasal spray. She is positioning the spray device in one nostril while using her finger to close the other nostril, demonstrating the proper technique for nasal spray administration.*

FDA Label Image

Figure F (Sumatriptannasalspray Spl Graphic 09)

An instructional image showing a woman demonstrating the proper use of a nasal spray device, presumably for sumatriptan nasal spray. The woman holds the spray with her fingers positioned on the actuator, poised near her nostril, illustrating how to administer the spray intranasally.*

FDA Label Image

Sumatriptan Nasal Spray 5 mg Carton (Sumatriptannasalspray Spl Graphic 10)

Packaging label for Sumatriptan Nasal Spray 5 mg by Prasco Laboratories. The label states a unit dose of 0.1 mL containing 5 mg of sumatriptan, intended for intranasal use only. The package contains 6 nasal spray units and is for prescription use.*

FDA Label Image

Sumatriptan Nasal Spray 20 mg Carton (Sumatriptannasalspray Spl Graphic 11)

Label for Sumatriptan Nasal Spray 20 mg in a 0.1 mL dosage form, manufactured by Prasco Laboratories. The label states the spray is for intranasal use, contains 6 nasal spray units per package, and is prescription only. It includes product branding and dosage instructions on the front panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.